July 5, 2021
Government Operations Results for May 2021
For the period of April to May 2021, the GOJ reported Total Revenues & Grants of $118.58 billion, $8.11 billion more than the Government’s projection. This represented an increase of approximately 58.9% relative to the $74.62 billion recorded for the corresponding period in 2020. ‘Tax Revenue’ and ‘Capital Revenue’ outperformed projections during the review period. ‘Tax Revenue’ amounted to $79.89 billion, $8.13 billion more than budgeted. ‘Capital Revenue’ amounted to $778.20 million during the review period. ‘Non-tax Revenue’ of $37.46 billion was reported, $555.7 million less than budgeted. “Grants” closed the period at $445.70 million, $242.80 million less than the budgeted amount. Notably, no budgeted amount was booked for ‘Bauxite Levy’ and ‘Capital Revenue’.
Expenditures
Total Expenditure for the period April to May 2021 amounted to $113.82 billion, $8.1 billion less than the budgeted amount of $121.92 billion. Recurrent expenditure which totalled $101.33 billion, accounted for 89.02% of overall expenditures. Of the recurrent expenditure categories for the review period, the categories above the budgeted amount were ‘Employee Contribution’ and ‘Interest’. ‘Employee Contribution’ amounted to $4.55 billion and was $201.20 million or 4.6% more than budgeted while ‘Interest’ totalled $18.80 billion, 3.1% above the budgeted amount of $18.23 billion. Relative to projections, ‘Programmes’ totalled $41.77 billion, 14% less than budgeted. Additionally, ‘Compensation of Employees’ totalled $40.75 billion, 0.6% less than the budgeted amount of $41.01 billion.
The ‘Fiscal Surplus’ was $4.76 billion, relative to a ‘Projected Deficit’ of $11.46 billion. Additionally, the ‘Primary Surplus Balance’ for the period amounted to $23.56 billion, relative to the budgeted Primary Surplus of $6.78 billion.
Disclaimer:
Analyst Certification –The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure –The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
